Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W6LW
|
||||
Former ID |
DCL001159
|
||||
Drug Name |
BIT225
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] | Phase 1 | [550378] | ||
Company |
Biotron
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H15N5O
|
||||
Canonical SMILES |
CN1C=C(C=N1)C2=CC=CC3=C2C=CC(=C3)C(=O)N=C(N)N
|
||||
InChI |
1S/C16H15N5O/c1-21-9-12(8-19-21)13-4-2-3-10-7-11(5-6-14(10)13)15(22)20-16(17)18/h2-9H,1H3,(H4,17,18,20,22)
|
||||
InChIKey |
WVROWPPEIMRGAB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | HIV protease | Target Info | Inhibitor | [550378] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.